Samuel D. Banister - Concepedia

Author

Samuel D. Banister

Also Known As

Banister, S.D., Banister, Samuel, Banister, Samuel D., S. Banister, Sam Banister, Samuel Banister, Samuel D Banister, Samuel D. Banister

119

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

The University of Sydney Macquarie University Stanford University University of California, San Francisco University of Auckland

About

Samuel D. Banister is an author at The University of Sydney specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	27	1.7K
2	Natural Sciences	13	14	923
3	Engineering	3	3	100
4	Health Sciences	1	1	43
5	Public Health	1	1	38

Samuel D. Banister

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex Kaavya Krishna Kumar, Moran Shalev-Benami, Michael J. Robertson, Cell Cannabis UseMolecular PharmacologySignal TransductionMolecular PhysiologyG Protein-coupled Receptor	2019	440
“Zombie” Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York Axel Adams, Samuel D. Banister, Lisandro Irizarry, New England Journal of Medicine	2016	318
Pharmacology of Valinate and<i>tert</i>-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues Samuel D. Banister, Mitchell Longworth, Richard C. Kevin, ACS Chemical Neuroscience	2016	246
Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA Samuel D. Banister, Michael Moir, Jordyn Stuart, ACS Chemical Neuroscience Cannabis UseMedicinal ChemistryDrug TargetPsychoactive DrugPharmacological Study	2015	239
Effects of Bioisosteric Fluorine in Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135 Samuel D. Banister, Jordyn Stuart, Richard C. Kevin, ACS Chemical Neuroscience Drug TargetPharmacotherapyExperimental PharmacologyCannabinoid PharmacologyPharmaceutical Chemistry	2015	194
The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonist New Psychoactive Substances: Evolution Samuel D. Banister, Mark Connor Handbook of experimental pharmacology Cannabis UseMolecular PharmacologyMedicinal ChemistryPsychoactive DrugBiochemistry	2018	125
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome Lyndsey L. Anderson, Ivan K. Low, Samuel D. Banister, Journal of Natural Products	2019	109
Detection of the recently emerged synthetic cannabinoid 5F–MDMB‐PICA in ‘legal high’ products and human urine samples Lukas Mogler, Florian Franz, Daniel Rentsch, Drug Testing and Analysis	2017	98
Synthesis and <i>in Vitro</i> Cannabinoid Receptor 1 Activity of Recently Detected Synthetic Cannabinoids 4F-MDMB-BICA, 5F-MPP-PICA, MMB-4en-PICA, CUMYL-CBMICA, ADB-BINACA, APP-BINACA, 4F-MDMB-BINACA, MDMB-4en-PINACA, A-CHMINACA, 5F-AB-P7AICA, 5F-MDMB-P7AICA, and 5F-AP7AICA Annelies Cannaert, Eric Sparkes, Edward Pike, ACS Chemical Neuroscience	2020	97
[18F]DPA-714: Direct Comparison with [11C]PK11195 in a Model of Cerebral Ischemia in Rats Hervé Boutin, C. Prenant, Renaud Maroy, PLoS ONE	2013	87

Page 1